Print Page  Close Window
Investor Overview
Company Overview
PDI is a leading health care commercialization company providing superior insight-driven, integrated multi-channel message delivery to established and emerging health care companies. The company is dedicated to enhancing engagement with health care practitioners and optimizing commercial investments for its clients by providing strategic flexibility, full product commercialization services, innovative multi-channel promotional solutions, and sales and marketing expertise.... More >>
Recent News
04/02/14Molecular Diagnostics Veteran, Greg Richard, Joins PDI, Inc. as General Manager for Interpace Diagnostics Subsidiary
PARSIPPANY, N.J., April 2, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), a market leader in healthcare product commercialization and integrated marketing services, has hired Greg Richard as General Manager for its Interpace Diagnostics subsidiary. Richard will be responsible for evolving and driving the execution of PDI's molecular diagnostics growth strategy.  "Molecular Diagnostics is a fast-growing market that represents a significant opportunity for PDI," said Nancy Lurker, chief exec... 
Printer Friendly Version
03/04/14PDI, Inc. to Present at the ROTH Capital Partners 26th Annual Growth Stock Conference
PARSIPPANY, N.J., March 4, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that Jeff Smith, the company's chief financial officer, is scheduled to present at the ROTH Capital Partners 26th Annual Growth Stock Conference at 4:30 pm PT on March 11, 2014 at the Ritz-Carlton Laguna Nigel in Dana Point, CA. The live webcast may be accessed under the "Investor Relations" tab on the company's website at The webcast will be archived for 30 days. About PDI, ... 
Printer Friendly Version
02/27/14PDI Reports 2013 Fourth Quarter and Full Year Financial Results
Management Will Host Conference Call Today February 27 at 5:00 pm ET PARSIPPANY, N.J., Feb. 27, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII), today reported financial and operational results for the fourth quarter and year ended December 31, 2013. Summary financial and operational accomplishments include: Revenues increased 19% to $150.8 million for the year and 2% to $36.4 million for the fourth quarter of 2013 as compared 2012 Adjusted EBITDA (a non-GAAP financial measure) of $(1.1)... 
Printer Friendly Version
02/18/14PDI, Inc. to Hold Fourth Quarter and Full Year 2013 Financial Results Conference Call on Thursday, February 27, 2014
PARSIPPANY, N.J., Feb. 18, 2014 /PRNewswire/ -- PDI, Inc. (Nasdaq: PDII) today announced that it will release its fourth quarter 2013 financial results on Thursday, February 27, 2014 after the market close and host a conference call beginning at 5:00 pm Eastern time to discuss the results. (Logo: ) Access information: Date:              Thursday, February 27, 2014 Time:            ... 
Printer Friendly Version
More >>

Primary IR Contact
Asher Dewhurst
Westwick Partners
Phone: 443.213.0503

Stock Quote
PDII (Common Stock)
ExchangeNASDAQ GM (US Dollar)
Change (%) Stock is Up 0.14 (2.80%)
Data as of 04/17/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.